Immune-related biomarkers for Parkinson's disease
Despite the increasing number of studies on Parkinson's disease and it being the second most common neurodegenerative disorder in the world, no established diagnostic markers or disease modifying therapies are available. Understanding the mechanisms involved in its pathogenesis and identifying...
Main Authors: | Ilham Y. Abdi, Simona S. Ghanem, Omar M. El-Agnaf |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996122001632 |
Similar Items
-
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
by: Tingting Du, et al.
Published: (2021-03-01) -
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
by: Anna Santaella, et al.
Published: (2020-01-01) -
Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up
by: Ilham Yahya Abdi, et al.
Published: (2023-02-01) -
Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson’s Disease
by: Dagmar H. Hepp, et al.
Published: (2023-10-01) -
Biomarker of Neuroinflammation in Parkinson’s Disease
by: Tsai-Wei Liu, et al.
Published: (2022-04-01)